Sanofi, joining other drug makers, slashes US insulin price

French pharmaceutical giant Sanofi announced on Thursday it would cut the US price of its most prescribed insulin by 78 percent, falling in line with two other major drug makers.

Eli Lilly announced this month it would cut the US price of its insulin by 70 percent and Novo Nordisk followed suit by saying it would lower the price by 75 percent.